购物车
- 全部删除
- 您的购物车当前为空
IOX4 是选择性 PHD2抑制剂,IC50=1.6 nM,在细胞和野生型小鼠中诱导 HIFα表达,可透过血脑屏障。它与 PHD2 特性位点的 2-氧代戊二酸竞争并置换。
为众多的药物研发团队赋能,
让新药发现更简单!
IOX4 是选择性 PHD2抑制剂,IC50=1.6 nM,在细胞和野生型小鼠中诱导 HIFα表达,可透过血脑屏障。它与 PHD2 特性位点的 2-氧代戊二酸竞争并置换。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 123 | 现货 | |
5 mg | ¥ 273 | 现货 | |
10 mg | ¥ 449 | 现货 | |
25 mg | ¥ 978 | 现货 | |
50 mg | ¥ 1,450 | 现货 | |
100 mg | ¥ 2,130 | 现货 | |
200 mg | ¥ 3,070 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 296 | 现货 |
产品描述 | IOX4 is a potent PHD2 inhibitor (IC50 = 1.6 nM) |
靶点活性 | PHD2:1.6 nM |
体内活性 | IOX4 as a highly potent and selective inhibitor of human PHD2, As shown by studies with mice, IOX4 is useful for in vivo work;?it will then be useful for investigations on the suitability of the PHDs as targets for cerebral diseases such as stroke.?The combined kinetic and biophysical analyses reveal that IOX4 (and IOX2) compete with 2OG for binding to PHD2;?the triazole rings of the inhibitors bind in the pocket occupied by the CH2CH2COOH side chain of 2OG.?The results thus reveal the potential of non-acid containing PHD inhibitors—an important finding given the potential of HIFα upregulation mediated by PHD inhibition in the treatment of stroke, as acids do not often permeate the blood-brain barrier efficiently[1]. |
分子量 | 328.33 |
分子式 | C15H16N6O3 |
CAS No. | 1154097-71-8 |
Smiles | CC(C)(C)OC(=O)c1ccc(nc1)-n1[nH]cc(-n2ccnn2)c1=O |
密度 | 1.41 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 83.33 mg/mL (253.80 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容